vs
花花公子（PLBY）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是花花公子的1.0倍（$35.5M vs $34.9M），花花公子净利率更高（10.3% vs -304.2%，领先314.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 4.2%），花花公子自由现金流更多（$1.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 11.0%）
花花公子集团（Playboy, Inc.）起源于1953年由休·海夫纳联合合伙人在美国芝加哥创立，初始部分资金来自海夫纳母亲提供的1000美元贷款，是美国知名生活方式与娱乐内容品牌，旗下核心《花花公子》杂志同时发行电子版与纸质版。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
PLBY vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.0倍
$34.9M
营收增速更快
RXRX
高出677.5%
4.2%
净利率更高
PLBY
高出314.5%
-304.2%
自由现金流更多
PLBY
多$48.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
11.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.9M | $35.5M |
| 净利润 | $3.6M | $-108.1M |
| 毛利率 | 73.3% | 59.8% |
| 营业利润率 | 7.9% | -304.8% |
| 净利率 | 10.3% | -304.2% |
| 营收同比 | 4.2% | 681.7% |
| 净利润同比 | 128.6% | 39.6% |
| 每股收益（稀释后） | $0.05 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLBYRXRX
| Q4 25 | $34.9M | $35.5M | ||
| Q3 25 | $29.0M | $5.2M | ||
| Q2 25 | $28.1M | $19.2M | ||
| Q1 25 | $28.9M | $14.7M | ||
| Q4 24 | $33.5M | $4.5M | ||
| Q3 24 | $29.4M | $26.1M | ||
| Q2 24 | $24.9M | $14.4M | ||
| Q1 24 | $28.3M | $13.8M |
净利润PLBYRXRX
| Q4 25 | $3.6M | $-108.1M | ||
| Q3 25 | $460.0K | $-162.3M | ||
| Q2 25 | $-7.7M | $-171.9M | ||
| Q1 25 | $-9.0M | $-202.5M | ||
| Q4 24 | $-12.5M | $-178.9M | ||
| Q3 24 | $-33.8M | $-95.8M | ||
| Q2 24 | $-16.7M | $-97.5M | ||
| Q1 24 | $-16.4M | $-91.4M |
毛利率PLBYRXRX
| Q4 25 | 73.3% | 59.8% | ||
| Q3 25 | 76.0% | -183.8% | ||
| Q2 25 | 65.4% | -4.9% | ||
| Q1 25 | 68.6% | -48.0% | ||
| Q4 24 | 70.8% | -181.4% | ||
| Q3 24 | 61.0% | 53.7% | ||
| Q2 24 | 67.8% | 36.2% | ||
| Q1 24 | 55.8% | 19.1% |
营业利润率PLBYRXRX
| Q4 25 | 7.9% | -304.8% | ||
| Q3 25 | 4.7% | -3327.6% | ||
| Q2 25 | -20.9% | -916.8% | ||
| Q1 25 | -21.7% | -1297.9% | ||
| Q4 24 | -13.3% | -4042.4% | ||
| Q3 24 | -96.0% | -377.1% | ||
| Q2 24 | -37.0% | -697.4% | ||
| Q1 24 | -31.5% | -698.4% |
净利率PLBYRXRX
| Q4 25 | 10.3% | -304.2% | ||
| Q3 25 | 1.6% | -3135.3% | ||
| Q2 25 | -27.3% | -894.2% | ||
| Q1 25 | -31.3% | -1373.3% | ||
| Q4 24 | -37.4% | -3935.5% | ||
| Q3 24 | -114.7% | -367.5% | ||
| Q2 24 | -66.9% | -676.6% | ||
| Q1 24 | -58.1% | -662.4% |
每股收益（稀释后）PLBYRXRX
| Q4 25 | $0.05 | $-0.17 | ||
| Q3 25 | $0.00 | $-0.36 | ||
| Q2 25 | $-0.08 | $-0.41 | ||
| Q1 25 | $-0.10 | $-0.50 | ||
| Q4 24 | $-0.13 | $-0.56 | ||
| Q3 24 | $-0.45 | $-0.34 | ||
| Q2 24 | $-0.23 | $-0.40 | ||
| Q1 24 | $-0.23 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.8M | $743.3M |
| 总债务越低越好 | $174.2M | $9.6M |
| 股东权益账面价值 | $18.4M | $1.1B |
| 总资产 | $292.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 9.48× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资PLBYRXRX
| Q4 25 | $37.8M | $743.3M | ||
| Q3 25 | $27.5M | $659.8M | ||
| Q2 25 | $19.6M | $525.1M | ||
| Q1 25 | $23.7M | $500.5M | ||
| Q4 24 | $30.9M | $594.4M | ||
| Q3 24 | $9.5M | $427.6M | ||
| Q2 24 | $16.9M | $474.3M | ||
| Q1 24 | $19.0M | $296.3M |
总债务PLBYRXRX
| Q4 25 | $174.2M | $9.6M | ||
| Q3 25 | $176.8M | $11.9M | ||
| Q2 25 | $177.5M | $14.2M | ||
| Q1 25 | $176.3M | $16.4M | ||
| Q4 24 | $176.6M | $19.0M | ||
| Q3 24 | $200.0M | $20.5M | ||
| Q2 24 | $196.3M | $22.9M | ||
| Q1 24 | $193.4M | — |
股东权益PLBYRXRX
| Q4 25 | $18.4M | $1.1B | ||
| Q3 25 | $3.8M | $1.0B | ||
| Q2 25 | $-17.5M | $919.1M | ||
| Q1 25 | $-11.4M | $933.9M | ||
| Q4 24 | $-7.7M | $1.0B | ||
| Q3 24 | $-15.7M | $524.6M | ||
| Q2 24 | $15.7M | $584.4M | ||
| Q1 24 | $29.5M | $401.2M |
总资产PLBYRXRX
| Q4 25 | $292.4M | $1.5B | ||
| Q3 25 | $278.3M | $1.4B | ||
| Q2 25 | $264.1M | $1.3B | ||
| Q1 25 | $270.6M | $1.3B | ||
| Q4 24 | $284.7M | $1.4B | ||
| Q3 24 | $271.5M | $726.5M | ||
| Q2 24 | $301.8M | $775.9M | ||
| Q1 24 | $309.1M | $557.8M |
负债/权益比PLBYRXRX
| Q4 25 | 9.48× | 0.01× | ||
| Q3 25 | 46.86× | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | 12.51× | 0.04× | ||
| Q1 24 | 6.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 3.2% | -133.1% |
| 资本支出强度资本支出/营收 | 0.8% | 3.5% |
| 现金转化率经营现金流/净利润 | 0.39× | — |
| 过去12个月自由现金流最近4个季度 | $-1.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流PLBYRXRX
| Q4 25 | $1.4M | $-46.1M | ||
| Q3 25 | $10.1M | $-117.4M | ||
| Q2 25 | $-3.9M | $-76.4M | ||
| Q1 25 | $-7.6M | $-132.0M | ||
| Q4 24 | $161.0K | $-115.4M | ||
| Q3 24 | $-6.5M | $-59.2M | ||
| Q2 24 | $-3.0M | $-82.2M | ||
| Q1 24 | $-9.8M | $-102.3M |
自由现金流PLBYRXRX
| Q4 25 | $1.1M | $-47.3M | ||
| Q3 25 | $9.8M | $-117.6M | ||
| Q2 25 | $-4.3M | $-79.6M | ||
| Q1 25 | $-7.7M | $-133.8M | ||
| Q4 24 | $-401.0K | $-116.7M | ||
| Q3 24 | $-7.0M | $-63.8M | ||
| Q2 24 | $-3.7M | $-83.4M | ||
| Q1 24 | $-10.3M | $-109.0M |
自由现金流率PLBYRXRX
| Q4 25 | 3.2% | -133.1% | ||
| Q3 25 | 33.8% | -2272.5% | ||
| Q2 25 | -15.2% | -413.9% | ||
| Q1 25 | -26.5% | -907.4% | ||
| Q4 24 | -1.2% | -2567.7% | ||
| Q3 24 | -23.7% | -244.6% | ||
| Q2 24 | -14.8% | -578.5% | ||
| Q1 24 | -36.5% | -789.9% |
资本支出强度PLBYRXRX
| Q4 25 | 0.8% | 3.5% | ||
| Q3 25 | 1.1% | 4.7% | ||
| Q2 25 | 1.4% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 1.7% | 28.6% | ||
| Q3 24 | 1.5% | 17.5% | ||
| Q2 24 | 2.6% | 8.2% | ||
| Q1 24 | 2.1% | 48.2% |
现金转化率PLBYRXRX
| Q4 25 | 0.39× | — | ||
| Q3 25 | 22.02× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLBY
| Transferred At Point In Time | $22.2M | 64% |
| Trademark Licensing | $6.5M | 19% |
| Related Party | $5.0M | 14% |
| Other | $1.1M | 3% |
RXRX
暂无分部数据
